Irritable bowel syndrome - Revision history

Ostermayer: Prepared the page for translation

2026-01-04T23:14:20Z

Prepared the page for translation

← Older revision		Revision as of 23:14, 4 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	==Background==		==Background==

	#psychosocial factors		#psychosocial factors
	#altered gut motility		#altered gut motility
	#hypersensitive intestinal pain perception		#hypersensitive intestinal pain perception


	==Evaluation==		==Evaluation==


	===Criteria===		===Criteria===
	#Three months of [[abdominal pain]]:
			#Three months of [[Special:MyLanguage/abdominal pain\|abdominal pain]]:
	##relieved by defecation		##relieved by defecation
	##associated with change of stool freq		##associated with change of stool freq
Line 16:		Line 24:
	##passage of mucous		##passage of mucous
	##bloating		##bloating


	==Workup==		==Workup==

	*Diagnosis of exclusion		*Diagnosis of exclusion


	==Differential Diagnosis==		==Differential Diagnosis==
	*[[Post-infectious irritable bowel syndrome]]
	*See [[abdominal pain]]		*[[Special:MyLanguage/Post-infectious irritable bowel syndrome\|Post-infectious irritable bowel syndrome]]
			*See [[Special:MyLanguage/abdominal pain\|abdominal pain]]


	==Management==		==Management==
	*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>
			*Consider prescribing [[Special:MyLanguage/ondansetron\|ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>
	*Typical bowel regimen treatments for IBS-C		*Typical bowel regimen treatments for IBS-C
	**May consider low-dose [[TCA]] if appropriate follow up with PCP will occur		**May consider low-dose [[Special:MyLanguage/TCA\|TCA]] if appropriate follow up with PCP will occur


	==See Also==		==See Also==
	*[[Abdominal Pain]]
	*[[Postinfectious irritable bowel syndrome]]		*[[Special:MyLanguage/Abdominal Pain\|Abdominal Pain]]
			*[[Special:MyLanguage/Postinfectious irritable bowel syndrome\|Postinfectious irritable bowel syndrome]]


	==External Links==		==External Links==


	===Patient Information===		===Patient Information===

	[http://digestive.niddk.nih.gov/ddiseases/pubs/ibs/ibs_508.pdf Irritable Bowel Syndrome] (National Digestive Diseases Information Clearinghouse)		[http://digestive.niddk.nih.gov/ddiseases/pubs/ibs/ibs_508.pdf Irritable Bowel Syndrome] (National Digestive Diseases Information Clearinghouse)


	==References==		==References==

	<references/>		<references/>

	[[Category:GI]]		[[Category:GI]]
			</translate>

ClaireLewis at 21:47, 29 September 2019

2019-09-29T21:47:45Z

← Older revision		Revision as of 21:47, 29 September 2019
Line 2:		Line 2:
	#psychosocial factors		#psychosocial factors
	#altered gut motility		#altered gut motility
	#hypersensitive intestinal pain ~~perseption~~		#hypersensitive intestinal pain perception

	==Evaluation==		==Evaluation==
	===Criteria===		===Criteria===
	#Three months of pain:		#Three months of [[abdominal pain]]:
	##relieved by defecation		##relieved by defecation
	##associated with change of stool freq		##associated with change of stool freq
Line 22:		Line 22:
	==Differential Diagnosis==		==Differential Diagnosis==
	*[[Post-infectious irritable bowel syndrome]]		*[[Post-infectious irritable bowel syndrome]]
			*See [[abdominal pain]]

	==Management==		==Management==
	*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>		*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>
	*Typical bowel regimen treatments for IBS-C		*Typical bowel regimen treatments for IBS-C
	**May consider low-dose TCA if appropriate follow up with PCP will occur		**May consider low-dose [[TCA]] if appropriate follow up with PCP will occur

	==See Also==		==See Also==

Kxl328: /* Management */

2018-10-17T04:59:54Z

Management

← Older revision		Revision as of 04:59, 17 October 2018
Line 26:		Line 26:
	*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>		*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>
	*Typical bowel regimen treatments for IBS-C		*Typical bowel regimen treatments for IBS-C
			**May consider low-dose TCA if appropriate follow up with PCP will occur

	==See Also==		==See Also==

Kxl328: /* Management */

2018-10-02T01:34:15Z

Management

← Older revision		Revision as of 01:34, 2 October 2018
Line 25:		Line 25:
	==Management==		==Management==
	*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>		*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>
			*Typical bowel regimen treatments for IBS-C

	==See Also==		==See Also==

Kxl328: /* Management */

2018-10-02T01:31:53Z

Management

← Older revision		Revision as of 01:31, 2 October 2018
Line 24:		Line 24:

	==Management==		==Management==
			*Consider prescribing [[ondansetron]] up to 24 mg/d for IBS-D<ref>Garsed K, Chernova J, Hastings M, et al. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625.</ref>

	==See Also==		==See Also==

Kxl328: /* Workup */

2018-10-02T01:30:58Z

Workup

← Older revision		Revision as of 01:30, 2 October 2018
Line 18:		Line 18:

	==Workup==		==Workup==
			*Diagnosis of exclusion

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1: Text replacement - "assoc " to "associated "

2016-08-24T21:43:33Z

Text replacement - "assoc " to "associated "

← Older revision		Revision as of 21:43, 24 August 2016
Line 8:		Line 8:
	#Three months of pain:		#Three months of pain:
	##relieved by defecation		##relieved by defecation
	##~~assoc~~ with change of stool freq		##associated with change of stool freq
	##related to a change in stool consistency		##related to a change in stool consistency
	#AND, 2 or more of the following symptoms 25% of the time		#AND, 2 or more of the following symptoms 25% of the time

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-23T23:23:31Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 23:23, 23 July 2016
Line 4:		Line 4:
	#hypersensitive intestinal pain perseption		#hypersensitive intestinal pain perseption

	==~~Diagnosis~~==		==Evaluation==
	===Criteria===		===Criteria===
	#Three months of pain:		#Three months of pain:

Neil.m.young: Text replacement - "# " to "#"

2016-07-06T00:16:04Z

Text replacement - "# " to "#"

← Older revision		Revision as of 00:16, 6 July 2016
Line 11:		Line 11:
	##related to a change in stool consistency		##related to a change in stool consistency
	#AND, 2 or more of the following symptoms 25% of the time		#AND, 2 or more of the following symptoms 25% of the time
	## >3 bm per day or < 3 bm per week		##>3 bm per day or < 3 bm per week
	## altered stool form		##altered stool form
	## altered stool passage		##altered stool passage
	## passage of mucous		##passage of mucous
	## bloating		##bloating

	==Workup==		==Workup==

Neil.m.young: Text replacement - "==Source ==" to "==References== "

2016-06-28T03:05:21Z

Text replacement - "==Source ==" to "==References== <references/>"

← Older revision		Revision as of 03:05, 28 June 2016
Line 32:		Line 32:
	[http://digestive.niddk.nih.gov/ddiseases/pubs/ibs/ibs_508.pdf Irritable Bowel Syndrome] (National Digestive Diseases Information Clearinghouse)		[http://digestive.niddk.nih.gov/ddiseases/pubs/ibs/ibs_508.pdf Irritable Bowel Syndrome] (National Digestive Diseases Information Clearinghouse)

	==~~Source~~ ==		==References==
			<references/>

	[[Category:GI]]		[[Category:GI]]